Key facts
- Veeva Summit focused on AI's role in the biopharmaceutical industry.
- Over 2,000 people attended the event.
- Industry leaders shared strategies for streamlining operations.
- Companies like GSK, Sanofi, and Roche participated.
The Veeva Summit brought together over 2,000 attendees to discuss the future of artificial intelligence within the biopharmaceutical sector. Key industry players, including AOP Health, Boehringer Ingelheim, GSK, Haleon, MSD, Novo Nordisk, Roche, Sanofi, and Sobi, were present. These leaders shared their insights and strategies focused on enhancing operational efficiency and connectivity within their organizations through AI. The event underscored the growing importance of AI in transforming biopharmaceutical operations.